Envision Healthcare to price $650 million eight-year notes Thursday

By Paul A. Harris

Portland, Ore., June 12 – Envision Healthcare Corp. plans to price a $650 million offering of eight-year senior notes (existing ratings B3/B) on Thursday following a late-morning conference call with investors, according to a syndicate source.

Barclays is the lead left bookrunner for the Rule 144A and Regulation S for life offering. BofA Merrill Lynch, Deutsche Bank Securities Inc., Goldman Sachs & Co., Citigroup Global Markets Inc., Jefferies LLC, Morgan Stanley & Co. LLC, Natixis, RBC Capital Markets and UBS Investment Bank are joint bookrunners.

The notes become callable after three years at par plus 75% of the coupon. There is a three-year 40% equity clawback at par plus the coupon and a 101% poison put.

The Greenwood Village, Colo.-based health care services provider plans to redeem its 8 1/8% senior notes due 2019.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.